Parkinson's disease: A complex interplay of mitochondrial DNA alterations and oxidative stress

International Journal of Molecular Sciences

Volumn 14, Issue 2, 2013, Pages 2388-2409

  Ciccone, Sarah ^a   Maiani, Emiliano ^a   Bellusci, Giovanna ^a   Diederich, Marc ^b,c   Gonfloni, Stefania ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Kirchberg Hospital   (Luxembourg)

^c Seoul National University   (South Korea)

Author keywords

Base excision repair (BER); C Abl; Mitochondria; Neurodegenerative diseases; Oxidative stress; Oxidized glutathione (GSS ); Parkinson's disease (PD); Reactive nitrogen species (RNS); Reactive oxidative species (ROS); Reduced glutathione (GSH)

Indexed keywords

ABELSON KINASE; ADENOSINE TRIPHOSPHATE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE;

AUTOPHAGY; DEGENERATIVE DISEASE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; HOMOLOGOUS RECOMBINATION; HUMAN; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL RESPIRATION; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; NUCLEIC ACID SYNTHESIS; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84875121203     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14022388     Document Type: Review

References (134)

1. Jeppesen, D.K.; Bohr, V.A.; Stevnsner, T. DNA repair deficiency in neurodegeneration. Prog. Neurobiol. 2011, 94, 166-200.
2. Hegde, M.L.; Mantha, A.K.; Hazra, T.K.; Bhakat, K.K.; Mitra, S.; Szczesny, B. Oxidative genome damage and its repair: Implications in aging and neurodegenerative diseases. Mech. Ageing Dev. 2012, 133, 157-168.
3. Bohgaki, T.; Bohgaki, M.; Hakem, R. DNA double-strand break signaling and human disorders. Genome Integr. 2010, 1, 15.
4. Dasuri, K.; Zhang, L.; Keller, J.N. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic. Biol. Med. 2012, doi:10.1016/j.freeradbiomed.2012.09.016.
5. Freitas, A.A.; de Magalhaes, J.P. A review and appraisal of the DNA damage theory of ageing. Mut. Res. 2011, 728, 12-22.
6. Polidori, M.C.; Griffiths, H.R.; Mariani, E.; Mecocci, P. Hallmarks of protein oxidative damage in neurodegenerative diseases: Focus on Alzheimer's disease. Amino Acids 2007, 32, 553-559.
7. Yan, M.H.; Wang, X.; Zhu, X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic. Biol. Med. 2012, doi:10.1016/j.freeradbiomed.2012.11.014.
8. Hsieh, R.H.; Hou, J.H.; Hsu, H.S.; Wei, Y.H. Age-dependent respiratory function decline and DNA deletions in human muscle mitochondria. Biochem. Mol. Biol. Int. 1994, 32, 1009-1022.
9. Lezza, A.M.; Boffoli, D.; Scacco, S.; Cantatore, P.; Gadaleta, M.N. Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles. Biochem. Biophys. Res. Commun. 1994, 205, 772-779.
10. Lax, N.Z.; Turnbull, D.M.; Reeve, A.K. Mitochondrial mutations: Newly discovered players in neuronal degeneration. Neuroscientist 2011, 17, 645-658.
11. Lee, H.C.; Pang, C.Y.; Hsu, H.S.; Wei, Y.H. Differential accumulations of 4,977 bp deletion in mitochondrial DNA of various tissues in human ageing. Biochim. Biophys. Acta 1994, 1226, 37-43.
12. Hayashi, M.; Miyata, R.; Tanuma, N. Oxidative stress in developmental brain disorders. Adv. Exp. Med. Biol. 2012, 724, 278-290.
13. Mecocci, P. Oxidative stress in mild cognitive impairment and Alzheimer disease: A continuum. J. Alzheimer's Dis. 2004, 6, 159-163.
14. Schlatterer, S.D.; Acker, C.M.; Davies, P. c-Abl in neurodegenerative disease. J. Mol. Neurosci. 2011, 45, 445-452.
15. Gonfloni, S. DNA damage stress response in germ cells: Role of c-Abl and clinical implications. Oncogene 2010, 29, 6193-6202.
16. Colicelli, J. ABL tyrosine kinases: Evolution of function, regulation, and specificity. Sci. Signal. 2010, 3, re6.
17. Shaul, Y.; Ben-Yehoyada, M. Role of c-Abl in the DNA damage stress response. Cell Res. 2005, 15, 33-35.
18. Gonfloni, S.; Maiani, E.; Di Bartolomeo, C.; Diederich, M.; Cesareni, G. Oxidative stress, DNA damage, and c-Abl signaling: At the crossroad in neurodegenerative diseases? Int. J. Cell Biol. 2012, 2012, 683097.
19. Schlatterer, S.D.; Tremblay, M.A.; Acker, C.M.; Davies, P. Neuronal c-Abl overexpression leads to neuronal loss and neuroinflammation in the mouse forebrain. J. Alzheimer's Dis. 2011, 25, 119-133.
20. Devine, M.J.; Plun-Favreau, H.; Wood, N.W. Parkinson's disease and cancer: Two wars, one front. Nat. Rev. Cancer 2011, 11, 812-823.
21. Nakamura, J.; Swenberg, J.A. Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res.1999, 59, 2522-2526.
22. Friedberg, E.C.; Aguilera, A.; Gellert, M.; Hanawalt, P.C.; Hays, J.B.; Lehmann, A.R.; Lindahl, T.; Lowndes, N.; Sarasin, A.; Wood, R.D. DNA repair: From molecular mechanism to human disease. DNA Repair 2006, 5, 986-996.
23. Liu, Y.; Wilson, S.H. DNA base excision repair: A mechanism of trinucleotide repeat expansion. Trends Biochem. Sci. 2012, 37, 162-172.
24. Caldecott, K.W. Single-strand break repair and genetic disease. Nat. Rev. Genet. 2008, 9, 619-631.
25. Cahill, D.; Connor, B.; Carney, J.P. Mechanisms of eukaryotic DNA double strand break repair. Front. Biosci. 2006, 11, 1958-1976.
26. Engels, W.R.; Johnson-Schlitz, D.; Flores, C.; White, L.; Preston, C.R. A third link connecting aging with double strand break repair. Cell Cycle 2007, 6, 131-135.
27. Chen, B.P.; Li, M.; Asaithamby, A. New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress. Cancer Lett. 2012, 327, 103-110.
28. Korwek, Z.; Sewastianik, T.; Bielak-Zmijewska, A.; Mosieniak, G.; Alster, O.; Moreno-Villaneuva, M.; Burkle, A.; Sikora, E. Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells. DNA Repair 2012, 11, 864-873.
29. Aziz, K.; Nowsheen, S.; Pantelias, G.; Iliakis, G.; Gorgoulis, V.G.; Georgakilas, A.G. Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy. Pharmacol. Ther. 2012, 133, 334-350.
30. Vyjayanti, V.N.; Rao, K.S. DNA double strand break repair in brain: Reduced NHEJ activity in aging rat neurons. Neurosci. Lett. 2006, 393, 18-22.
31. Niedernhofer, L.J. Tissue-specific accelerated aging in nucleotide excision repair deficiency. Mechanisms of ageing and development. Mech. Ageing Dev. 2008, 129, 408-415.
32. Fousteri, M.; Mullenders, L.H. Transcription-coupled nucleotide excision repair in mammalian cells: Molecular mechanisms and biological effects. Cell Res. 2008, 18, 73-84.
33. Shuck, S.C.; Short, E.A.; Turchi, J.J. Eukaryotic nucleotide excision repair: From understanding mechanisms to influencing biology. Cell Res. 2008, 18, 64-72.
34. Fishel, M.L.; Vasko, M.R.; Kelley, M.R. DNA repair in neurons: So if they don't divide what's to repair? Mut. Res. 2007, 614, 24-36.
35. Maynard, S.; Schurman, S.H.; Harboe, C.; de Souza-Pinto, N.C.; Bohr, V.A. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2009, 30, 2-10.
36. Jiricny, J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 2006, 7, 335-346.
37. Kunkel, T.A.; Erie, D.A. DNA mismatch repair. Ann. Rev. Biochem.2005, 74, 681-710.
38. Hong, Z.; Jiang, J.; Hashiguchi, K.; Hoshi, M.; Lan, L.; Yasui, A. Recruitment of mismatch repair proteins to the site of DNA damage in human cells. J. Cell Sci. 2008, 121, 3146-3154.
39. Conde-Perezprina, J.C.; Leon-Galvan, M.A.; Konigsberg, M. DNA mismatch repair system: Repercussions in cellular homeostasis and relationship with aging. Oxid. Med. Cell. Longevity 2012, 2012, 728430.
40. Lujan, S.A.; Williams, J.S.; Pursell, Z.F.; Abdulovic-Cui, A.A.; Clark, A.B.; Nick McElhinny, S.A.; Kunkel, T.A. Mismatch repair balances leading and lagging strand DNA replication fidelity. PLoS Genet. 2012, 8, e1003016.
41. Lenaz, G. The mitochondrial production of reactive oxygen species: Mechanisms and implications in human pathology. IUBMB Life 2001, 52, 159-164.
42. Osellame, L.D.; Blacker, T.S.; Duchen, M.R. Cellular and molecular mechanisms of mitochondrial function. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26, 711-723.
43. Sorolla, M.A.; Rodriguez-Colman, M.J.; Vall-llaura, N.; Tamarit, J.; Ros, J.; Cabiscol, E. Protein oxidation in Huntington disease. Biofactors 2012, 38, 173-185.
44. Zadori, D.; Klivenyi, P.; Szalardy, L.; Fulop, F.; Toldi, J.; Vecsei, L. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders. J. Neurol. Sci. 2012, 322, 187-191.
45. Gasparre, G.; Romeo, G.; Rugolo, M.; Porcelli, A.M. Learning from oncocytic tumors: Why choose inefficient mitochondria? Biochim. Biophys. Acta 2011, 1807, 633-642.
46. Karbownik-Lewi Ska, M.G.; St Pniak, J.; Lewi Ski, A. High level of oxidized nucleosides in thyroid mitochondrial DNA; damaging effects of Fenton reaction substrates. Thyroid Res. 2012, 5, 24.
47. Wallace, D.C. Mitochondrial DNA mutations in disease and aging. Environ. Mol. Mutagen. 2010, 51, 440-450.
48. Zhao, D.; Wang, Z.; Hong, D.; Zhang, W.; Yuan, Y. Chronic progressive external ophthalmoplegia coexistent with motor neuron disease in a patient with a novel large-scale mitochondrial DNA deletion. Clin. Neurol. Neurosurg. 2012, doi:10.1016/j.clineuro.2012.11.011.
49. Comte, C.; Tonin, Y.; Heckel-Mager, A.M.; Boucheham, A.; Smirnov, A.; Aure, K.; Lornbes, A.; Martin, R.P.; Entelis, N.; Tarassov, I. Mitochondrial targeting of recombinant RNAs modulates the level of a heteroplasmic mutation in human mitochondrial DNA associated with Kearns Sayre Syndrome. Nucleic Acids Res. 2013, 41, 418-433.
50. Caporali, L.; Ghelli, A.M.; Iommarini, L.; Maresca, A.; Valentino, M.L.; La Morgia, C.; Liguori, R.; Zanna, C.; Barboni, P.; De Nardo, V.; et al. Cybrid studies establish the causal link between the mtDNA m.3890G>A/MT-ND1 mutation and optic atrophy with bilateral brainstem lesions. Biochim. Biophys. Acta 2012, 1832, 445-452.
51. Tschampa, H.J.; Urbach, H.; Greschus, S.; Kunz, W.S.; Kornblum, C. Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation. J. Neurol. 2012, doi:10.1007/s00415-012-6763-4.
52. Lopez-Gallardo, E.; Solano, A.; Herrero-Martin, M.D.; Martinez-Romero, I.; Castano-Perez, M.D.; Andreu, A.L.; Herrera, A.; López-Pérez, M.J.; Ruiz-Pesini, E.; Montoya, J. NARP syndrome in a patient harbouring an insertion in the MT-ATP6 gene that results in a truncated protein. J. Med. Genet. 2009, 46, 64-67.
53. Goto, Y.; Nonaka, I.; Horai, S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 348, 651-653.
54. Shoffner, J.M.; Lott, M.T.; Lezza, A.M.; Seibel, P.; Ballinger, S.W.; Wallace, D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990, 61, 931-937.
55. Monden, Y.; Mori, M.; Kuwajima, M.; Goto, T.; Yamagata, T.; Momoi, M.Y. Late-onset Leigh syndrome with myoclonic epilepsy with ragged-red fibers. Brain Dev. 2012, doi:10.1016/j.braindev.2012.08.006.
56. Barja, G.; Herrero, A. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J. 2000, 14, 312-318.
57. Mecocci, P.; MacGarvey, U.; Kaufman, A.E.; Koontz, D.; Shoffner, J.M.; Wallace, D.C.; Beal, M.F. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 1993, 34, 609-616.
58. Wei, Y.H.; Lee, H.C. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp. Biol. Med. (Maywood) 2002, 227, 671-682.
59. Lin, M.T.; Beal, M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443, 787-795.
60. Albers, D.S.; Beal, M.F. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural Transm. Suppl. 2000, 59, 133-154.
61. Lee, C.K.; Weindruch, R.; Prolla, T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 2000, 25, 294-297.
62. Greaves, L.C.; Elson, J.L.; Nooteboom, M.; Grady, J.P.; Taylor, G.A.; Taylor, R.W.; Mathers, J.C.; Kirkwood, T.B.; Turnbull, D.M. Comparison of mitochondrial mutation spectra in ageing human colonic epithelium and disease: Absence of evidence for purifying selection in somatic mitochondrial DNA point mutations. PLoS Genet. 2012, 8, e1003082.
63. Lee, H.C.; Chang, C.M.; Chi, C.W. Somatic mutations of mitochondrial DNA in aging and cancer progression. Ageing Res. Rev. 2010, 9, S47-S58.
64. Ashrafi, G.; Schwarz, T.L. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2012, 20, 31-42.
65. Youle, R.J.; van der Bliek, A.M. Mitochondrial fission, fusion, and stress. Science 2012, 337, 1062-1065.
66. De Souza-Pinto, N.C.; Mason, P.A.; Hashiguchi, K.; Weissman, L.; Tian, J.; Guay, D.; Lebel, M.; Stevnsner, T.V.; Rasmussen, L.J.; Bohr, V.A. Novel DNA mismatch-repair activity involving YB-1 in human mitochondria. DNA Repair 2009, 8, 704-719.
67. Gredilla, R. DNA damage and base excision repair in mitochondria and their role in aging. J. Aging Res. 2010, 2011, 257093.
68. Lauritzen, K.H.; Moldestad, O.; Eide, L.; Carlsen, H.; Nesse, G.; Storm, J.F.; Mansuy, I.M.; Bergersen, L.H.; Klungland, A. Mitochondrial DNA toxicity in forebrain neurons causes apoptosis, neurodegeneration, and impaired behavior. Mol. Cell. Biol. 2010, 30, 1357-1367.
69. Mitra, S.; Izumi, T.; Boldogh, I.; Bhakat, K.K.; Chattopadhyay, R.; Szczesny, B. Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein. DNA Repair 2007, 6, 461-469.
70. Martin, L.J. Biology of mitochondria in neurodegenerative diseases. Prog. Mol. Biol. Transl. Sci. 2012, 107, 355-415.
71. Larsen, N.B.; Rasmussen, M.; Rasmussen, L.J. Nuclear and mitochondrial DNA repair: Similar pathways? Mitochondrion 2005, 5, 89-108.
72. Gredilla, R.; Bohr, V.A.; Stevnsner, T. Mitochondrial DNA repair and association with aging-An update. Exp. Gerontol. 2010, 45, 478-488.
73. Chakrabarti, S.; Munshi, S.; Banerjee, K.; Thakurta, I.G.; Sinha, M.; Bagh, M.B. Mitochondrial dysfunction during brain aging: Role of oxidative stress and modulation by antioxidant supplementation. Aging Dis. 2011, 2, 242-256.
74. Federico, A.; Cardaioli, E.; Da Pozzo, P.; Formichi, P.; Gallus, G.N.; Radi, E. Mitochondria, oxidative stress and neurodegeneration. J. Neurol. Sci. 2012, 322, 254-262.
75. Filosto, M.; Scarpelli, M.; Cotelli, M.S.; Vielmi, V.; Todeschini, A.; Gregorelli, V.; Tonin, P.; Tomelleri, G.; Padovani, A. The role of mitochondria in neurodegenerative diseases. J. Neurol. 2011, 258, 1763-1774.
76. Loeb, L.A.; Wallace, D.C.; Martin, G.M. The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. Proc. Natl. Acad. Sci. USA 2005, 102, 18769-18770.
77. Nicholls, D.G. Oxidative stress and energy crises in neuronal dysfunction. Ann. N. Y. Acad. Sci. 2008, 1147, 53-60.
78. Lee, H.C.; Wei, Y.H. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int. J. Biochem. Cell Biol. 2005, 37, 822-834.
79. Scarpulla, R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 2008, 88, 611-638.
80. Cheng, X.; Siow, R.C.; Mann, G.E. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: A role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid. Redox Signal. 2011, 14, 469-487.
81. Kensler, T.W.; Wakabayashi, N.; Biswal, S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Ann. Rev. Pharmacol. Toxicol. 2007, 47, 89-116.
82. Niture, S.K.; Kaspar, J.W.; Shen, J.; Jaiswal, A.K. Nrf2 signaling and cell survival. Toxicol. Appl. Pharmacol. 2010, 244, 37-42.
83. Ozanne, B.; Wheeler, T.; Zack, J.; Smith, G.; Dale, B. Transforming gene of a human leukaemia cell is unrelated to the expressed tumour virus related gene of the cell. Nature 1982, 299, 744-747.
84. Maiani, E.; Diederich, M.; Gonfloni, S. DNA damage response: The emerging role of c-Abl as a regulatory switch? Biochem. Pharmacol. 2011, 82, 1269-1266.
85. Herrup, K. Reimagining Alzheimer's disease-An age-based hypothesis. J. Neurosci. 2010, 30, 16755-16762.
86. Jing, Z.; Caltagarone, J.; Bowser, R. Altered subcellular distribution of c-Abl in Alzheimer's disease. J. Alzheimer's Dis. 2009, 17, 409-422.
87. Kharbanda, S.; Ren, R.; Pandey, P.; Shafman, T.D.; Feller, S.M.; Weichselbaum, R.R.; Kufe, D.W. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 1995, 376, 785-788.
88. Cancino, G.I.; Toledo, E.M.; Leal, N.R.; Hernandez, D.E.; Yévenes, L.F.; Inestrosa, N.C.; Alvarez, A.R. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. Brain 2008, 131, 2425-2442.
89. Ko, H.S.; Lee, Y.; Shin, J.H.; Karuppagounder, S.S.; Gadad, B.S.; Koleske, A.J.; Pletnikova, O.; Troncoso, J.C.; Dawson, V.L.; Dawson, T.M. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc. Natl Acad. Sci. USA 2010, 107, 16691-16696.
90. Cancino, G.I.; Perez de Arce, K.; Castro, P.U.; Toledo, E.M.; von Bernhardi, R.; Alvarez, A.R. c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice. Neurobiol. Aging 2011, 32, 1249-1261.
91. Cacciatore, I.; Baldassarre, L.; Fornasari, E.; Mollica, A.; Pinnen, F. Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. Oxid. Med. Cell. Longevity 2012, 2012, 240146.
92. Bains, J.S.; Shaw, C.A. Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Brain Res. Rev. 1997, 25, 335-358.
93. Garrido, M.; Tereshchenko, Y.; Zhevtsova, Z.; Taschenberger, G.; Bahr, M.; Kugler, S. Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons. Acta Neuropathol. 2011, 121, 475-485.
94. Drake, J.; Kanski, J.; Varadarajan, S.; Tsoras, M.; Butterfield, D.A. Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J. Neurosci. Res. 2002, 68, 776-784.
95. Hayes, J.D.; Flanagan, J.U.; Jowsey, I.R. Glutathione transferases. Ann. Rev. pharmacol. Toxicol. 2005, 45, 51-88.
96. Wilce, M.C.; Parker, M.W. Structure and function of glutathione S-transferases. Biochim. Biophys. Acta 1994, 1205, 1-18.
97. Nuccetelli, M.; Mazzetti, A.P.; Rossjohn, J.; Parker, M.W.; Board, P.; Caccuri, A.M.; Federici, G.; Ricci, G.; Lo Bello, M. Shifting substrate specificity of human glutathione transferase (from class Pi to class alpha) by a single point mutation. Biochem. Biophys. Res. Commun. 1998, 252, 184-189.
98. Fabrini, R.; de Luca, A.; Stella, L.; Mei, G.; Orioni, B.; Ciccone, S.; Federici, G.; Lo Bello, M.; Ricci, G. Monomer-dimer equilibrium in glutathione transferases: A critical re-examination. Biochemistry 2009, 48, 10473-10482.
99. Chen, J.; Liou, A.; Zhang, L.; Weng, Z.; Gao, Y.; Cao, G.; Zigmond, M.J.; Chen, J. GST P1, a novel downstream regulator of LRRK2, G2019S-induced neuronal cell death. Front. Biosci. 2012, 4, 2365-2377.
100. Jankovic, J. Parkinson's disease: Clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 2008, 79, 368-376.
101. Zhou, C.; Huang, Y.; Przedborski, S. Oxidative stress in Parkinson's disease: A mechanism of pathogenic and therapeutic significance. Ann. N. Y. Acad. Sci. 2008, 1147, 93-104.
102. Chinta, S.J.; Andersen, J.K. Redox imbalance in Parkinson's disease. Biochim. Biophys. Acta 2008, 1780, 1362-1367.
103. Hirsch, E.C.; Brandel, J.P.; Galle, P.; Javoy-Agid, F.; Agid, Y. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: An X-ray microanalysis. J. Neurochem. 1991, 56, 446-451.
104. Chung, K.K.; Zhang, Y.; Lim, K.L.; Tanaka, Y.; Huang, H.; Gao, J.; Ross, C.A.; Dawson, V.L.; Dawson, T.M. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease. Nat. Med. 2001, 7, 1144-1150.
105. Chung, K.K.; Thomas, B.; Li, X.; Pletnikova, O.; Troncoso, J.C.; Marsh, L.; Dawson, V.L.; Dawson, T.M. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 2004, 304, 1328-1331.
106. Kitada, T.; Asakawa, S.; Hattori, N.; Matsumine, H.; Yamamura, Y.; Minoshima, S.; Yokochi, M.; Mizuno, Y.; Shimizu, N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392, 605-608.
107. Moore, D.J.; West, A.B.; Dawson, V.L.; Dawson, T.M. Molecular pathophysiology of Parkinson's disease. Ann. Rev. Neurosci. 2005, 28, 57-87.
108. Blalock, E.M.; Chen, K.C.; Sharrow, K.; Herman, J.P.; Porter, N.M.; Foster, T.C.; Landfield, P.W. Gene microarrays in hippocampal aging: Statistical profiling identifies novel processes correlated with cognitive impairment. J. Neurosci. 2003, 23, 3807-3819.
109. Shulman, L.M.; Singer, C.; Bean, J.A.; Weiner, W.J. Internal tremor in patients with Parkinson's disease. Mov. Disord. 1996, 11, 3-7.
110. Villarejo, A.; Camacho, A.; García-Ramos, R.; Moreno, T.; Penas, M.; Juntas, R.; Ruiz, J. Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin. Neuropharmacol. 2003, 26, 119-121.
111. Berardelli, A.; Rothwell, J.C.; Thompson, P.D.; Hallett, M. Pathophysiology of bradykinesia in Parkinson's disease. Brain 2001, 124, 2131-2146.
112. Stefani, A.; Lozano, A.M.; Peppe, A.; Stanzione, P.; Galati, S.; Tropepi, D.; Pierantozzi, M.; Brusa, L.; Scarnati, E.; Mazzone, P. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007, 130, 1596-1607.
113. Zesiewicz, T.A.; Sullivan, K.L.; Hauser, R.A. Nonmotor symptoms of Parkinson's disease. Expert Rev. Neurother. 2006, 6, 1811-1822.
114. Zhu, M.; Li, W.; Lu, C. Role of alpha-synuclein protein levels in mitochondrial morphology and cell survival in cell lines. PLoS One 2012, 7, e36377.
115. Nakamura, K.; Nemani, V.M.; Azarbal, F.; Skibinski, G.; Levy, J.M.; Egami, K.; Munishkina, L.; Zhang, J.; Gardner, B.; Wakabayashi, J.; et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J. Biol. Chem. 2011, 286, 20710-20726.
116. Elkon, H.; Don, J.; Melamed, E.; Ziv, I.; Shirvan, A.; Offen, D. Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase. J. Mol. Neurosci. 2002, 18, 229-238.
117. Braak, H.; Braak, E. Pathoanatomy of Parkinson's disease. J. Neurol. 2000, 247, II3-II10.
118. Arduino, D.M.; Esteves, A.R.; Cardoso, S.M. Mitochondria drive autophagy pathology via microtubule disassembly: A new hypothesis for Parkinson disease. Autophagy 2012, 9, 112-114.
119. Pienaar, I.S.; Chinnery, P.F. Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression. Pharmacol. Ther. 2012, doi:10.1016/j.pharmthera.2012.08.010.
120. Greene, A.W.; Grenier, K.; Aguileta, M.A.; Muise, S.; Farazifard, R.; Haque, M.E.; McBride, H.M.; Park, D.S.; Fon, E.A. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 2012, 13, 378-385.
121. Pridgeon, J.W.; Olzmann, J.A.; Chin, L.S.; Li, L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 2007, 5, e172.
122. Heeman, B.; Van den Haute, C.; Aelvoet, S.A.; Valsecchi, F.; Rodenburg, R.J.; Reumers, V.; Debyser, Z.; Callewaert, G.; Koopman, W.J.; Willems, P.H.; et al. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. J. Cell Sci. 2011, 124, 1115-1125.
123. Zhou, C.; Huang, Y.; Shao, Y.; May, J.; Prou, D.; Perier, C.; Dauer, W.; Schon, E.A.; Przedborski, S. The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc. Natl. Acad. Sci. USA 2008, 105, 12022-1207.
124. Wood-Kaczmar, A.; Gandhi, S.; Yao, Z.; Abramov, A.Y.; Miljan, E.A.; Keen, G.; Stanyer, L.; Hargreaves, I.; Klupsch, K.; Deas, E.; et al. PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One 2008, 3, e2455.
125. Marongiu, R.; Spencer, B.; Crews, L.; Adame, A.; Patrick, C.; Trejo, M.; Dallapiccola, B.; Valente, E.M.; Masliah, E. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J. Neurochem. 2009, 108, 1561-1574.
126. Shimura, H.; Hattori, N.; Kubo, S.i.; Mizuno, Y.; Asakawa, S.; Minoshima, S.; Shimizu, N.; Iwai, K.; Chiba, T.; Tanaka, K.; et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 2000, 25, 302-305.
127. Shimura, H.; Hattori, N.; Kubo, S.; Yoshikawa, M.; Kitada, T.; Matsumine, H.; Asakawa, S.; Minoshima, S.; Yamamura, Y.; Shimizu, N.; et al. Immunohistochemical and subcellular localization of Parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 1999, 45, 668-672.
128. Narendra, D.P.; Jin, S.M.; Tanaka, A.; Suen, D.F.; Gautier, C.A.; Shen, J.; Cookson, M.R.; Youle, R.J. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010, 8, e1000298.
129. Jenner, P.; Olanow, C.W. Understanding cell death in Parkinson's disease. Ann. Neurol. 1998, 44, S72-S84.
130. Pickrell, A.M.; Pinto, M.; Hida, A.; Moraes, C.T. Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's disease. J. Neurosci. 2011, 31, 17649-17658.
131. Grespi, F.; Melino, G. P73 and age-related diseases: Is there any link with Parkinson Disease? Aging 2012, Available online: http://www.impactaging.com/papers/v4/n12/full/100515.html (accessed on 5 December 2012).
132. Imam, S.Z.; Zhou, Q.; Yamamoto, A.; Valente, A.J.; Ali, S.F.; Bains, M.; Roberts, J.L.; Kahle, P.J.; Clark, R.A.; Li, S. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: Implications for Parkinson's disease. J. Neurosci. 2011, 31, 157-163.
133. Xiao, L.; Chen, D.; Hu, P.; Wu, J.; Liu, W.; Zhao, Y.; Cao, M.; Fang, Y.; Bi, W.; Zheng, Z.; et al. The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death. J. Neurosci 2011, 31, 9611-9619.
134. Zhang, Y.; Dawson, V.L.; Dawson, T.M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 2000, 7, 240-250.